CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Standard Biotools Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Standard Biotools Inc
2 Tower Place, Suite 2000
Phone: (650) 266-6000p:650 266-6000 SOUTH SAN FRANCISCO, CA  94080  United States Ticker: LABLAB
Business Summary
Standard BioTools Inc. develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines. The Company's segments include Proteomics and Genomics. The Proteomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of genes and their functions. The Company provides insights in health and disease using its mass cytometry and microfluidics technologies, which serve applications in proteomics and genomic. It works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories around the world, focusing on the needs in translational and clinical research, including oncology, immunology, and immunotherapy. The Company also provides differentiated multi-omics tools for research.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023YesYes--Yes

Industries
SIC Code Description
3826 Laboratory analytical instruments

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board TomCarey 62 1/5/2024 1/5/2024
President, Chief Executive Officer, Director MichaelEgholm 61 4/4/2022 4/4/2022
Chief Financial Officer Hanjoon A.Kim 53 11/11/2024 4/4/2022
4 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
DVS Sciences, Inc. 639 N. Pastoria Ave Sunnyvale CA United States
Somalogic Inc C/O Somalogic BOULDER CO United States

Business Names
Business Name
DVS Sciences, Inc.
FLDM
Fluidigm (Shanghai) Instrument Technology Company Limited
26 additional Business Names available in full report.

General Information
Number of Employees: 534 (As of 12/31/2023)
Outstanding Shares: 372,258,798 (As of 11/1/2024)
Shareholders: 267
Stock Exchange: NASD
Federal Tax Id: 770513190
Fax Number: (302) 655-5049


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024